CHEMED CORP (CHE) Stock Fundamental Analysis

NYSE:CHE • US16359R1032

473.22 USD
+9.27 (+2%)
At close: Feb 13, 2026
473.22 USD
0 (0%)
After Hours: 2/13/2026, 8:04:00 PM
Fundamental Rating

7

Overall CHE gets a fundamental rating of 7 out of 10. We evaluated CHE against 102 industry peers in the Health Care Providers & Services industry. CHE gets an excellent profitability rating and is at the same time showing great financial health properties. CHE has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

  • In the past year CHE was profitable.
  • In the past year CHE had a positive cash flow from operations.
  • CHE had positive earnings in each of the past 5 years.
  • In the past 5 years CHE always reported a positive cash flow from operatings.
CHE Yearly Net Income VS EBIT VS OCF VS FCFCHE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 17.17%, CHE belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • With an excellent Return On Equity value of 25.89%, CHE belongs to the best of the industry, outperforming 91.18% of the companies in the same industry.
  • CHE has a better Return On Invested Capital (21.27%) than 97.06% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CHE is significantly above the industry average of 8.97%.
Industry RankSector Rank
ROA 17.17%
ROE 25.89%
ROIC 21.27%
ROA(3y)17.25%
ROA(5y)18.8%
ROE(3y)27.61%
ROE(5y)32.28%
ROIC(3y)21.96%
ROIC(5y)22.92%
CHE Yearly ROA, ROE, ROICCHE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

  • CHE has a better Profit Margin (11.02%) than 95.10% of its industry peers.
  • In the last couple of years the Profit Margin of CHE has grown nicely.
  • With an excellent Operating Margin value of 14.60%, CHE belongs to the best of the industry, outperforming 87.25% of the companies in the same industry.
  • CHE's Operating Margin has improved in the last couple of years.
  • CHE has a better Gross Margin (32.88%) than 63.73% of its industry peers.
  • In the last couple of years the Gross Margin of CHE has grown nicely.
Industry RankSector Rank
OM 14.6%
PM (TTM) 11.02%
GM 32.88%
OM growth 3Y-0.29%
OM growth 5Y3.39%
PM growth 3Y-0.36%
PM growth 5Y1.83%
GM growth 3Y-0.79%
GM growth 5Y1.99%
CHE Yearly Profit, Operating, Gross MarginsCHE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

9

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CHE is creating value.
  • CHE has less shares outstanding than it did 1 year ago.
  • CHE has less shares outstanding than it did 5 years ago.
  • There is no outstanding debt for CHE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CHE Yearly Shares OutstandingCHE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
CHE Yearly Total Debt VS Total AssetsCHE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • An Altman-Z score of 12.23 indicates that CHE is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 12.23, CHE belongs to the top of the industry, outperforming 96.08% of the companies in the same industry.
  • CHE has a debt to FCF ratio of 0.00. This is a very positive value and a sign of high solvency as it would only need 0.00 years to pay back of all of its debts.
  • With an excellent Debt to FCF ratio value of 0.00, CHE belongs to the best of the industry, outperforming 94.12% of the companies in the same industry.
  • A Debt/Equity ratio of 0.00 indicates that CHE is not too dependend on debt financing.
  • CHE has a better Debt to Equity ratio (0.00) than 85.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 12.23
ROIC/WACC2.45
WACC8.68%
CHE Yearly LT Debt VS Equity VS FCFCHE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 1.35 indicates that CHE should not have too much problems paying its short term obligations.
  • CHE has a Current ratio (1.35) which is in line with its industry peers.
  • CHE has a Quick Ratio of 1.33. This is a normal value and indicates that CHE is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of CHE (1.33) is comparable to the rest of the industry.
  • CHE does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.35
Quick Ratio 1.33
CHE Yearly Current Assets VS Current LiabilitesCHE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

3

3. Growth

3.1 Past

  • The earnings per share for CHE have decreased by -3.97% in the last year.
  • Measured over the past years, CHE shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.64% on average per year.
  • CHE shows a small growth in Revenue. In the last year, the Revenue has grown by 6.45%.
  • Measured over the past years, CHE shows a small growth in Revenue. The Revenue has been growing by 4.63% on average per year.
EPS 1Y (TTM)-3.97%
EPS 3Y6.14%
EPS 5Y10.64%
EPS Q2Q%-6.56%
Revenue 1Y (TTM)6.45%
Revenue growth 3Y4.36%
Revenue growth 5Y4.63%
Sales Q2Q%3.09%

3.2 Future

  • Based on estimates for the next years, CHE will show a small growth in Earnings Per Share. The EPS will grow by 6.76% on average per year.
  • Based on estimates for the next years, CHE will show a small growth in Revenue. The Revenue will grow by 5.01% on average per year.
EPS Next Y-3.31%
EPS Next 2Y5.31%
EPS Next 3Y6.13%
EPS Next 5Y6.76%
Revenue Next Year5.02%
Revenue Next 2Y5.54%
Revenue Next 3Y5.17%
Revenue Next 5Y5.01%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CHE Yearly Revenue VS EstimatesCHE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B 2.5B
CHE Yearly EPS VS EstimatesCHE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 10 20 30

4

4. Valuation

4.1 Price/Earnings Ratio

  • CHE is valuated rather expensively with a Price/Earnings ratio of 21.51.
  • Based on the Price/Earnings ratio, CHE is valued a bit cheaper than the industry average as 67.65% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Earnings ratio of 26.68, CHE is valued at the same level.
  • Based on the Price/Forward Earnings ratio of 18.44, the valuation of CHE can be described as rather expensive.
  • Based on the Price/Forward Earnings ratio, CHE is valued a bit cheaper than 65.69% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of CHE to the average of the S&P500 Index (28.06), we can say CHE is valued slightly cheaper.
Industry RankSector Rank
PE 21.51
Fwd PE 18.44
CHE Price Earnings VS Forward Price EarningsCHE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as CHE.
  • Based on the Price/Free Cash Flow ratio, CHE is valued a bit cheaper than the industry average as 67.65% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 18.59
EV/EBITDA 15.15
CHE Per share dataCHE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150

4.3 Compensation for Growth

  • The excellent profitability rating of CHE may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)2.02
EPS Next 2Y5.31%
EPS Next 3Y6.13%

6

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.52%, CHE is not a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 0.48, CHE pays a better dividend. On top of this CHE pays more dividend than 81.37% of the companies listed in the same industry.
  • With a Dividend Yield of 0.52, CHE pays less dividend than the S&P500 average, which is at 1.84.
Industry RankSector Rank
Dividend Yield 0.52%

5.2 History

  • On average, the dividend of CHE grows each year by 8.02%, which is quite nice.
  • CHE has been paying a dividend for at least 10 years, so it has a reliable track record.
  • CHE has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)8.02%
Div Incr Years16
Div Non Decr Years21
CHE Yearly Dividends per shareCHE Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

  • CHE pays out 11.01% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of CHE is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP11.01%
EPS Next 2Y5.31%
EPS Next 3Y6.13%
CHE Yearly Income VS Free CF VS DividendCHE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
CHE Dividend Payout.CHE Dividend Payout, showing the Payout Ratio.CHE Dividend Payout.PayoutRetained Earnings

CHEMED CORP

NYSE:CHE (2/13/2026, 8:04:00 PM)

After market: 473.22 0 (0%)

473.22

+9.27 (+2%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-28
Earnings (Next)02-25
Inst Owners101.64%
Inst Owner Change39.85%
Ins Owners1.52%
Ins Owner Change-2.29%
Market Cap6.70B
Revenue(TTM)2.53B
Net Income(TTM)278.81M
Analysts82.5
Price Target566.61 (19.74%)
Short Float %4.46%
Short Ratio4.25
Dividend
Industry RankSector Rank
Dividend Yield 0.52%
Yearly Dividend1.83
Dividend Growth(5Y)8.02%
DP11.01%
Div Incr Years16
Div Non Decr Years21
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-8.99%
Min EPS beat(2)-15.11%
Max EPS beat(2)-2.88%
EPS beat(4)1
Avg EPS beat(4)-4.45%
Min EPS beat(4)-15.11%
Max EPS beat(4)0.5%
EPS beat(8)2
Avg EPS beat(8)-3.19%
EPS beat(12)4
Avg EPS beat(12)-2.23%
EPS beat(16)8
Avg EPS beat(16)-1.06%
Revenue beat(2)0
Avg Revenue beat(2)-1.85%
Min Revenue beat(2)-2.53%
Max Revenue beat(2)-1.17%
Revenue beat(4)0
Avg Revenue beat(4)-1.07%
Min Revenue beat(4)-2.53%
Max Revenue beat(4)-0.19%
Revenue beat(8)0
Avg Revenue beat(8)-1.28%
Revenue beat(12)2
Avg Revenue beat(12)-1.05%
Revenue beat(16)2
Avg Revenue beat(16)-1.24%
PT rev (1m)-3.27%
PT rev (3m)-3.98%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.01%
EPS NY rev (1m)-0.17%
EPS NY rev (3m)-0.06%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)0.14%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.04%
Valuation
Industry RankSector Rank
PE 21.51
Fwd PE 18.44
P/S 2.65
P/FCF 18.59
P/OCF 15.97
P/B 6.22
P/tB 20.63
EV/EBITDA 15.15
EPS(TTM)22
EY4.65%
EPS(NY)25.66
Fwd EY5.42%
FCF(TTM)25.46
FCFY5.38%
OCF(TTM)29.64
OCFY6.26%
SpS178.72
BVpS76.04
TBVpS22.94
PEG (NY)N/A
PEG (5Y)2.02
Graham Number194.01
Profitability
Industry RankSector Rank
ROA 17.17%
ROE 25.89%
ROCE 27.75%
ROIC 21.27%
ROICexc 23.56%
ROICexgc 62.89%
OM 14.6%
PM (TTM) 11.02%
GM 32.88%
FCFM 14.24%
ROA(3y)17.25%
ROA(5y)18.8%
ROE(3y)27.61%
ROE(5y)32.28%
ROIC(3y)21.96%
ROIC(5y)22.92%
ROICexc(3y)25.21%
ROICexc(5y)25.79%
ROICexgc(3y)67.33%
ROICexgc(5y)75.46%
ROCE(3y)28.73%
ROCE(5y)30.03%
ROICexgc growth 3Y-5.61%
ROICexgc growth 5Y0.34%
ROICexc growth 3Y-1.58%
ROICexc growth 5Y4.43%
OM growth 3Y-0.29%
OM growth 5Y3.39%
PM growth 3Y-0.36%
PM growth 5Y1.83%
GM growth 3Y-0.79%
GM growth 5Y1.99%
F-Score7
Asset Turnover1.56
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 92.02%
Cap/Sales 2.34%
Interest Coverage 250
Cash Conversion 96.74%
Profit Quality 129.28%
Current Ratio 1.35
Quick Ratio 1.33
Altman-Z 12.23
F-Score7
WACC8.68%
ROIC/WACC2.45
Cap/Depr(3y)89.59%
Cap/Depr(5y)94.39%
Cap/Sales(3y)2.41%
Cap/Sales(5y)2.56%
Profit Quality(3y)107.8%
Profit Quality(5y)110.23%
High Growth Momentum
Growth
EPS 1Y (TTM)-3.97%
EPS 3Y6.14%
EPS 5Y10.64%
EPS Q2Q%-6.56%
EPS Next Y-3.31%
EPS Next 2Y5.31%
EPS Next 3Y6.13%
EPS Next 5Y6.76%
Revenue 1Y (TTM)6.45%
Revenue growth 3Y4.36%
Revenue growth 5Y4.63%
Sales Q2Q%3.09%
Revenue Next Year5.02%
Revenue Next 2Y5.54%
Revenue Next 3Y5.17%
Revenue Next 5Y5.01%
EBIT growth 1Y-7.92%
EBIT growth 3Y4.05%
EBIT growth 5Y8.18%
EBIT Next Year14.67%
EBIT Next 3Y10.29%
EBIT Next 5Y9.62%
FCF growth 1Y39.38%
FCF growth 3Y13.77%
FCF growth 5Y8.19%
OCF growth 1Y30.35%
OCF growth 3Y10.6%
OCF growth 5Y6.75%

CHEMED CORP / CHE FAQ

What is the fundamental rating for CHE stock?

ChartMill assigns a fundamental rating of 7 / 10 to CHE.


What is the valuation status of CHEMED CORP (CHE) stock?

ChartMill assigns a valuation rating of 4 / 10 to CHEMED CORP (CHE). This can be considered as Fairly Valued.


Can you provide the profitability details for CHEMED CORP?

CHEMED CORP (CHE) has a profitability rating of 9 / 10.


Can you provide the financial health for CHE stock?

The financial health rating of CHEMED CORP (CHE) is 9 / 10.


What is the earnings growth outlook for CHEMED CORP?

The Earnings per Share (EPS) of CHEMED CORP (CHE) is expected to decline by -3.31% in the next year.